The association of depressive symptoms and serum estradiol and testosterone levels in postmenopausal wome

Not Applicable

• Conditions: Anxiety, Estradiol, Testosterone, Healthy postmenopausal womenAge 50- 65 years Visit doctor for health check up; Depression, Depressive symptoms, Postmenopausal women

• Registration Number: TCTR20200720002
• Lead Sponsor: Chulalongkorn University (New instructor fund)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2020-07-20
• Study Completion: 2020-12-31
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Pending (Not yet recruiting)
• Sex: Female
• Target Recruitment: 165

Inclusion Criteria

- Natural postmenopausal women, age 50 - 65 years
- Visit doctor for health check up

Exclusion Criteria

-Receive estrogens or testosterone treatment within 12 months
-History or current use of selective serotonin reuptake inhibitor, serotonin norepinephrine reuptake inhibitor, or tricyclic antidepressant
-Known or suspected depressive, anxiety disorder, and other neuropsychological diseases
-Drug illicit, malnutrition
-Presence of hot flushes
-Presence of any cancer, severe infection, severe illness or stress

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Association between depressive symptoms and serum estradiol cross section PHQ 9, HAMD scale,Association between depressive symptoms and serum testosterone cross section PHQ 9, HAMD scale

Secondary Outcome Measures

Name	Time	Method
Association between anxiety symptoms and serum estradiol cross section HAMA scale,Association between anxiety symptoms and serum testosterone cross section HAMA scale